Stefan Both
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stefan Both has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Johannes Albertus Langendijk
Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
13 shared publications - Nanna Maria Sijtsema
Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
5 shared publications - Charlotte L. Brouwer
University Medical Center Groningen, Dept. Of Radiation Oncology, Groningen, The Netherlands
4 shared publications - Erik. W. Korevaar
Department of Radiotherapy, Universitair Medisch Centrum Groningen, PO Box 30 001, Groningen, 9700 RB, NETHERLANDS
4 shared publications - Peter Martinus Adranius van Ooijen
University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, the Netherlands
4 shared publications - Alessia De Biase
University Medical Center Groningen (UMCG)
3 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (21) , 215009
A fast and reliable quality assurance framework for CBCT-based synthetic CTs for adaptive proton radiotherapy
Objective. Cone-beam CT based synthetic CTs (sCTs) enable online adaptive proton therapy (PT) by preserving daily patient anatomy without additional acquisition of diagnostic-quality CTs. However, clinical adoption is limited by the lack of fast, reliable quality-assurance (QA) methods. This study proposes and evaluates a practical QA workflow to assess sCT suitability for proton dose optimization. Approach. A two-step sCT-QA workflow was developed in which a candidate sCT intended for reoptimization reference sCT (sCTref) is compared with an independently generated secondary sCT (sCTtest). The workflow combines image-based metrics and dose-based metrics, with doses derived from recalculating a template proton plan on both sCTs. In this study, the framework was evaluated using a deformably propagated virtual CT (vCT) as sCTref and either a deep learning-based sCT (sCTDL) or an analytically corrected CBCT (CBCTcorr) as sCTtest. Same-day CTs were deformably registered to the CBCT and used as ground truth (CT GT ) for evaluation. Thresholds were optimized using 5-fold cross-validation on 182 head-and-neck (H&N) CT-CBCT pairs. Dose calculation suitability was defined as a gamma pass rate (2%, 1 mm) exceeding 95% between dose distributions computed on sCT and CT GT . The method was further tested on an external H&N dataset and on abdominal cases. Main results. Optimal classification performance was achieved using a combination of image mean absolute error (MAE) and dose MAE. On the H&N test set, the workflow achieved balanced accuracies of 91.2% and 89.7% for the vCT-CBCTcorr and vCT-sCTDL comparisons, respectively, while maintaining a low false positive rate. When applied without modifications to the external H&N and abdominal datasets, balanced accuracy was 94.7% (HN) and 85.0% (abdominal) for vCT-CBCTcorr, and 37.9% (HN) and 61.1% (abdominal) for vCT-sCTDL. Significance. This study introduces a clinically feasible sCT-QA workflow for CBCT-based adaptive PT and showed promising transferability across datasets.
- 2 November 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (21) , 215009
Open AccessA fast and reliable quality assurance framework for CBCT-based synthetic CTs for adaptive proton radiotherapy
Objective. Cone-beam CT based synthetic CTs (sCTs) enable online adaptive proton therapy (PT) by preserving daily patient anatomy without additional acquisition of diagnostic-quality CTs. However, clinical adoption is limited by the lack of fast, reliable quality-assurance (QA) methods. This study proposes and evaluates a practical QA workflow to assess sCT suitability for proton dose optimization. Approach. A two-step sCT-QA workflow was developed in which a candidate sCT intended for reoptimization reference sCT (sCTref) is compared with an independently generated secondary sCT (sCTtest). The workflow combines image-based metrics and dose-based metrics, with doses derived from recalculating a template proton plan on both sCTs. In this study, the framework was evaluated using a deformably propagated virtual CT (vCT) as sCTref and either a deep learning-based sCT (sCTDL) or an analytically corrected CBCT (CBCTcorr) as sCTtest. Same-day CTs were deformably registered to the CBCT and used as ground truth (CT GT ) for evaluation. Thresholds were optimized using 5-fold cross-validation on 182 head-and-neck (H&N) CT-CBCT pairs. Dose calculation suitability was defined as a gamma pass rate (2%, 1 mm) exceeding 95% between dose distributions computed on sCT and CT GT . The method was further tested on an external H&N dataset and on abdominal cases. Main results. Optimal classification performance was achieved using a combination of image mean absolute error (MAE) and dose MAE. On the H&N test set, the workflow achieved balanced accuracies of 91.2% and 89.7% for the vCT-CBCTcorr and vCT-sCTDL comparisons, respectively, while maintaining a low false positive rate. When applied without modifications to the external H&N and abdominal datasets, balanced accuracy was 94.7% (HN) and 85.0% (abdominal) for vCT-CBCTcorr, and 37.9% (HN) and 61.1% (abdominal) for vCT-sCTDL. Significance. This study introduces a clinically feasible sCT-QA workflow for CBCT-based adaptive PT and showed promising transferability across datasets.
- Open Access
- 2 April 2026
- Published by Elsevier in SSRN Electronic Journal
Comparation of CT/PET/MRI in deep learning models for outcome prediction in oropharyngeal cancer patients
Background and Purpose: Due to superior soft tissue contrast, MRI may provide more prognostic information than CT/PET for outcome prediction. This study aims to compare the prognostic value of MRI with CT and PET in deep learning models for local control, regional control and overall survival in oropharyngeal cancer patients compared to a clinical benchmark model.Materials and Methods: A dataset comprising 266 oropharyngeal cancer patients was assembled. Each patient’s data includes pretreatment axial T1 and a coronal T2 MRI scan, CT and PET scans, gross tumor volume of the primary tumor, clinical parameters and information on local control, regional control and overall survival. Various 2D and 3D convolutional neural networks were trained using images of contoured gross tumor volume with and without a margin for outcome prediction.Results: The 2D models using T2 images within a bounding box region determined by the gross tumor volume achieved concordance index of 0.88 and 0.75 for local control and overall survival prediction, respectively. Additionally, MRI-based models achieved higher concordance indexes than CT- or PET-based models for local control prediction. In comparison to a clinical benchmark model, the T2-based 2D model showed improved local control prediction (concordance index: 0.88 vs. 0.80), and combining the T2 prediction with clinical model improved overall survival prediction (concordance index 0.81 vs. 0.78). Furthermore, the clinical + MRI models showed enhanced performance compared to a clinical routine survival risk stratification system.Conclusions: MRI-based deep learning models can improve prediction of local control and overall survival in oropharyngeal cancer.
- 2 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessComparation of CT/PET/MRI in deep learning models for outcome prediction in oropharyngeal cancer patients
Background and Purpose: Due to superior soft tissue contrast, MRI may provide more prognostic information than CT/PET for outcome prediction. This study aims to compare the prognostic value of MRI with CT and PET in deep learning models for local control, regional control and overall survival in oropharyngeal cancer patients compared to a clinical benchmark model.Materials and Methods: A dataset comprising 266 oropharyngeal cancer patients was assembled. Each patient’s data includes pretreatment axial T1 and a coronal T2 MRI scan, CT and PET scans, gross tumor volume of the primary tumor, clinical parameters and information on local control, regional control and overall survival. Various 2D and 3D convolutional neural networks were trained using images of contoured gross tumor volume with and without a margin for outcome prediction.Results: The 2D models using T2 images within a bounding box region determined by the gross tumor volume achieved concordance index of 0.88 and 0.75 for local control and overall survival prediction, respectively. Additionally, MRI-based models achieved higher concordance indexes than CT- or PET-based models for local control prediction. In comparison to a clinical benchmark model, the T2-based 2D model showed improved local control prediction (concordance index: 0.88 vs. 0.80), and combining the T2 prediction with clinical model improved overall survival prediction (concordance index 0.81 vs. 0.78). Furthermore, the clinical + MRI models showed enhanced performance compared to a clinical routine survival risk stratification system.Conclusions: MRI-based deep learning models can improve prediction of local control and overall survival in oropharyngeal cancer.
- Open Access
- 12 March 2026
- Published by Elsevier in SSRN Electronic Journal
Monitoring plan quality in clinically integrated deep learning-based IMPT planning for oropharyngeal cancer patients
Background and Purpose: With deep learning becoming an integral component of radiotherapy planning, it is critical to verify its consistency during clinical deployment. This study monitored the plan quality of clinically integrated deep learning (DL)–based planning for generating robustly optimized intensity modulated proton therapy (IMPT) plans in oropharyngeal carcinoma. Materials and methods: A U net–based DL model in the RayStation planning system predicted dose distributions, followed by robust dose mimicking to generate a standard DL optimized plan (sDLO). Dosimetrists refined the sDLO to create the manually adjusted DLO (mDLO) plan used for treatment. Plan quality of all mDLO plans was evaluated for 78 patients in a multidisciplinary meeting. To assess long term performance across the 28 month routine clinical use, manual benchmark plans were generated for 16 patients (every fifth patient). Quantitative evaluation included target coverage (CTV D98 ≥ 94 %, voxel wise minimum and maximum), organ at risk (OAR) doses, and normal tissue complication probabilities (NTCP) for grade ≥2 dysphagia and xerostomia. Results: All 78 mDLO plans (100%) were clinically acceptable. In the benchmark cohort, 14/16 mDLO plans (87.5%) met all clinical goals. Mean parotid dose was significantly lower in mDLO plans compared with manual plans (15.8 Gy (RBE) vs 16.9 Gy (RBE), p = 0.002). Manual refinement increased the number of patients meeting all clinical goals from 59 to 68. Conclusion: Clinically integrated deep learning–based IMPT planning consistently produced high‑quality, clinically acceptable plans for all 78 patients, with plan quality maintained during 28 months of routine clinical use.
- 12 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMonitoring plan quality in clinically integrated deep learning-based IMPT planning for oropharyngeal cancer patients
Background and Purpose: With deep learning becoming an integral component of radiotherapy planning, it is critical to verify its consistency during clinical deployment. This study monitored the plan quality of clinically integrated deep learning (DL)–based planning for generating robustly optimized intensity modulated proton therapy (IMPT) plans in oropharyngeal carcinoma. Materials and methods: A U net–based DL model in the RayStation planning system predicted dose distributions, followed by robust dose mimicking to generate a standard DL optimized plan (sDLO). Dosimetrists refined the sDLO to create the manually adjusted DLO (mDLO) plan used for treatment. Plan quality of all mDLO plans was evaluated for 78 patients in a multidisciplinary meeting. To assess long term performance across the 28 month routine clinical use, manual benchmark plans were generated for 16 patients (every fifth patient). Quantitative evaluation included target coverage (CTV D98 ≥ 94 %, voxel wise minimum and maximum), organ at risk (OAR) doses, and normal tissue complication probabilities (NTCP) for grade ≥2 dysphagia and xerostomia. Results: All 78 mDLO plans (100%) were clinically acceptable. In the benchmark cohort, 14/16 mDLO plans (87.5%) met all clinical goals. Mean parotid dose was significantly lower in mDLO plans compared with manual plans (15.8 Gy (RBE) vs 16.9 Gy (RBE), p = 0.002). Manual refinement increased the number of patients meeting all clinical goals from 59 to 68. Conclusion: Clinically integrated deep learning–based IMPT planning consistently produced high‑quality, clinically acceptable plans for all 78 patients, with plan quality maintained during 28 months of routine clinical use.
- Open Access
- 9 October 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (20) , 205011
Surface imaging to evaluate the dosimetric impact of breast deformations in proton and photon therapy for breast cancer
Objectives. Breast cancer patients treated with proton therapy receive weekly repeat CTs (rCT) for treatment evaluation. However, plan adaptations are rarely necessary in our department. Therefore, the goal of this study was to develop an online method using surface guided radiotherapy (SGRT) to predict the dosimetric impact of changes in breast anatomy to identify patients that require plan adaptations, in order to reduce the number of rCTs. Approach. Seven breast cancer patients, treated with proton therapy with daily 3D surface-images in treatment position used for SGRT, were included. Clinical proton and backup photon plans were available. A novel in-house developed method, Dose Impact Prediction from Surface Imaging (DIPSI), was used to quantify the deformation between the planning CT (pCT) BODY contour, and the daily 3D SGRT surface images. To validate DIPSI, known isotropic deformations of 2, 4, 6, 8, 10 and 15 mm were introduced in the pCT BODY contour surrounding the clinical target volume (CTV). Clinical proton and photon treatment plans were recalculated including this deformation to evaluate the dosimetric impact of known deformations on the CTV D98%, D2% and average dose (Dmean). Deformation thresholds were determined to detect unacceptable dose deviations, from which the corresponding sensitivity, specificity and false negative rate were determined. Main results. DIPSI showed an accuracy of 0.2 mm and perfect correlation with known deformations (R 2 = 1.00). Optimal thresholds to trigger treatment plan adaptation were 6.0 mm for the proton plan and 10.0 mm for the photon plan, resulting in sensitivities >95.5%, specificities >93.9% and false negative rates Significance. Breast surface deformations could accurately be determined from daily SGRT images, making them suitable in identifying patients that require plan adaptations in photon and proton therapy potentially reducing the need for rCTs.
- 9 October 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (20) , 205011
Open AccessSurface imaging to evaluate the dosimetric impact of breast deformations in proton and photon therapy for breast cancer
Objectives. Breast cancer patients treated with proton therapy receive weekly repeat CTs (rCT) for treatment evaluation. However, plan adaptations are rarely necessary in our department. Therefore, the goal of this study was to develop an online method using surface guided radiotherapy (SGRT) to predict the dosimetric impact of changes in breast anatomy to identify patients that require plan adaptations, in order to reduce the number of rCTs. Approach. Seven breast cancer patients, treated with proton therapy with daily 3D surface-images in treatment position used for SGRT, were included. Clinical proton and backup photon plans were available. A novel in-house developed method, Dose Impact Prediction from Surface Imaging (DIPSI), was used to quantify the deformation between the planning CT (pCT) BODY contour, and the daily 3D SGRT surface images. To validate DIPSI, known isotropic deformations of 2, 4, 6, 8, 10 and 15 mm were introduced in the pCT BODY contour surrounding the clinical target volume (CTV). Clinical proton and photon treatment plans were recalculated including this deformation to evaluate the dosimetric impact of known deformations on the CTV D98%, D2% and average dose (Dmean). Deformation thresholds were determined to detect unacceptable dose deviations, from which the corresponding sensitivity, specificity and false negative rate were determined. Main results. DIPSI showed an accuracy of 0.2 mm and perfect correlation with known deformations (R 2 = 1.00). Optimal thresholds to trigger treatment plan adaptation were 6.0 mm for the proton plan and 10.0 mm for the photon plan, resulting in sensitivities >95.5%, specificities >93.9% and false negative rates Significance. Breast surface deformations could accurately be determined from daily SGRT images, making them suitable in identifying patients that require plan adaptations in photon and proton therapy potentially reducing the need for rCTs.
- Open Access
- 7 May 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (10) , 105007
Potential toxicity benefit and inter-fraction robustness of proton arc therapy compared to IMPT and VMAT for nasopharyngeal cancer patients
Objective. Radiotherapy in nasopharyngeal cancer (NPC) patients presents challenges due to proximity of many anatomical structures to the target volume. Furthermore, inter-fractional changes must be considered to assure target coverage. Proton arc therapy (PAT) potentially reduces healthy tissue dose compared to IMPT and VMAT. The impact of PAT on dose to organs-at-risk (OARs), predicted acute-and late radiation toxicities and robust target coverage to inter-fraction changes in NPC patients were investigated. Approach. Robustly optimized PAT plans were compared to clinical VMAT and IMPT plans for 10 NPC patients treated with 70.00 Gy to the primary target (CTV 7000) and 54.25 Gy to the prophylactic lymph nodal area (CTV 5425). Integral body dose and mean and max in 0.03cc dose (D mean and max D0.03cc) in OARs were compared. Normal tissue complication probability (NTCP) values for 22 acute and late radiation-induced toxicities were evaluated. A PAT ‘base approach’ and nine PAT planning approaches to improve PAT inter-fraction robust target coverage were investigated. Target coverage was evaluated on in total 54 weekly repeated CT images (rCTs). Main results. PAT integral dose reduced by on average 55% and 15% compared with clinical VMAT and IMPT, respectively. Compared to IMPT, average D mean and max D0.03cc were significantly reduced in all evaluated neurological structures. Compared to IMPT, in the PAT plans D mean was reduced most in the arytenoids, PCM medius and brainstem by on average 8.0 Gy, 6.4 Gy and 6.1 Gy, respectively and all evaluated NTCP’s for both acute and late timepoint were significantly reduced. Compared with IMPT, PAT base approach target coverage on rCTs was worse. Approaches to improve PAT inter-fraction target coverage were successful, while maintaining the reduction in NTCP compared to IMPT. Significance. Compared to IMPT and VMAT, PAT reduces healthy tissue dose and subsequent estimated toxicity risks in NPC patients. PAT planning approaches to improve inter-fraction robustness were employed successfully, while NTCP benefits of PAT were maintained.
- 7 May 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (10) , 105007
Open AccessPotential toxicity benefit and inter-fraction robustness of proton arc therapy compared to IMPT and VMAT for nasopharyngeal cancer patients
Objective. Radiotherapy in nasopharyngeal cancer (NPC) patients presents challenges due to proximity of many anatomical structures to the target volume. Furthermore, inter-fractional changes must be considered to assure target coverage. Proton arc therapy (PAT) potentially reduces healthy tissue dose compared to IMPT and VMAT. The impact of PAT on dose to organs-at-risk (OARs), predicted acute-and late radiation toxicities and robust target coverage to inter-fraction changes in NPC patients were investigated. Approach. Robustly optimized PAT plans were compared to clinical VMAT and IMPT plans for 10 NPC patients treated with 70.00 Gy to the primary target (CTV 7000) and 54.25 Gy to the prophylactic lymph nodal area (CTV 5425). Integral body dose and mean and max in 0.03cc dose (D mean and max D0.03cc) in OARs were compared. Normal tissue complication probability (NTCP) values for 22 acute and late radiation-induced toxicities were evaluated. A PAT ‘base approach’ and nine PAT planning approaches to improve PAT inter-fraction robust target coverage were investigated. Target coverage was evaluated on in total 54 weekly repeated CT images (rCTs). Main results. PAT integral dose reduced by on average 55% and 15% compared with clinical VMAT and IMPT, respectively. Compared to IMPT, average D mean and max D0.03cc were significantly reduced in all evaluated neurological structures. Compared to IMPT, in the PAT plans D mean was reduced most in the arytenoids, PCM medius and brainstem by on average 8.0 Gy, 6.4 Gy and 6.1 Gy, respectively and all evaluated NTCP’s for both acute and late timepoint were significantly reduced. Compared with IMPT, PAT base approach target coverage on rCTs was worse. Approaches to improve PAT inter-fraction target coverage were successful, while maintaining the reduction in NTCP compared to IMPT. Significance. Compared to IMPT and VMAT, PAT reduces healthy tissue dose and subsequent estimated toxicity risks in NPC patients. PAT planning approaches to improve inter-fraction robustness were employed successfully, while NTCP benefits of PAT were maintained.
- Open Access
- 10 December 2024
- Published by MDPI AG in Journal of Imaging
- Vol. 10 (12) , 316
Toward Closing the Loop in Image-to-Image Conversion in Radiotherapy: A Quality Control Tool to Predict Synthetic Computed Tomography Hounsfield Unit Accuracy
In recent years, synthetic Computed Tomography (CT) images generated from Magnetic Resonance (MR) or Cone Beam Computed Tomography (CBCT) acquisitions have been shown to be comparable to real CT images in terms of dose computation for radiotherapy simulation. However, until now, there has been no independent strategy to assess the quality of each synthetic image in the absence of ground truth. In this work, we propose a Deep Learning (DL)-based framework to predict the accuracy of synthetic CT in terms of Mean Absolute Error (MAE) without the need for a ground truth (GT). The proposed algorithm generates a volumetric map as an output, informing clinicians of the predicted MAE slice-by-slice. A cascading multi-model architecture was used to deal with the complexity of the MAE prediction task. The workflow was trained and tested on two cohorts of head and neck cancer patients with different imaging modalities: 27 MR scans and 33 CBCT. The algorithm evaluation revealed an accurate HU prediction (a median absolute prediction deviation equal to 4 HU for CBCT-based synthetic CTs and 6 HU for MR-based synthetic CTs), with discrepancies that do not affect the clinical decisions made on the basis of the proposed estimation. The workflow exhibited no systematic error in MAE prediction. This work represents a proof of concept about the feasibility of synthetic CT evaluation in daily clinical practice, and it paves the way for future patient-specific quality assessment strategies.
- 10 December 2024
- Published by MDPI AG in Journal of Imaging
- Vol. 10 (12) , 316
Open AccessToward Closing the Loop in Image-to-Image Conversion in Radiotherapy: A Quality Control Tool to Predict Synthetic Computed Tomography Hounsfield Unit Accuracy
In recent years, synthetic Computed Tomography (CT) images generated from Magnetic Resonance (MR) or Cone Beam Computed Tomography (CBCT) acquisitions have been shown to be comparable to real CT images in terms of dose computation for radiotherapy simulation. However, until now, there has been no independent strategy to assess the quality of each synthetic image in the absence of ground truth. In this work, we propose a Deep Learning (DL)-based framework to predict the accuracy of synthetic CT in terms of Mean Absolute Error (MAE) without the need for a ground truth (GT). The proposed algorithm generates a volumetric map as an output, informing clinicians of the predicted MAE slice-by-slice. A cascading multi-model architecture was used to deal with the complexity of the MAE prediction task. The workflow was trained and tested on two cohorts of head and neck cancer patients with different imaging modalities: 27 MR scans and 33 CBCT. The algorithm evaluation revealed an accurate HU prediction (a median absolute prediction deviation equal to 4 HU for CBCT-based synthetic CTs and 6 HU for MR-based synthetic CTs), with discrepancies that do not affect the clinical decisions made on the basis of the proposed estimation. The workflow exhibited no systematic error in MAE prediction. This work represents a proof of concept about the feasibility of synthetic CT evaluation in daily clinical practice, and it paves the way for future patient-specific quality assessment strategies.
- Open Access
- 26 July 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 31, 100616
A planning study of proton therapy dose escalation for non-small cell lung cancer
- 26 July 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 31, 100616
Open AccessA planning study of proton therapy dose escalation for non-small cell lung cancer
- Open Access
- 19 June 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 31, 100600
Target coverage and organs at risk dose in hypofractionated salvage radiotherapy after prostatectomy
- 19 June 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 31, 100600
Open AccessTarget coverage and organs at risk dose in hypofractionated salvage radiotherapy after prostatectomy
- Open Access
- 21 March 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Applied Superconductivity
- Vol. 34 (5) , 1-5
Magnetic Design of a Compact GaToroid for Very High Energy Electron and Pre-Clinical Hadron Beams
GaToroid is a novel configuration of a beam delivery system for charged particles therapy based on a steady-state, axis-symmetric field configuration. The basic idea is to use fixed toroidal magnets, producing an axis-symmetric (or periodical axis-symmetric) field configuration that can bend beams from several directions onto the patient location. In principle, neither magnets nor patient need to be moved. In addition, the field of the magnets of this toroidal gantry is static. Such system is perfectly adapted to FLASH therapy, a novel method of beam dose delivery that has shown benefits for electrons and potential for hadrons. In this paper we describe the magnetic design of a “compact GaToroid”, which could be built with iron-dominated magnets, suitable for 200 MeV electron beams, as well as protons at 70 MeV. The gantry profits from the use of toroidal quadrupoles, which greatly simplify the beam transmission. An additional novelty is the use of a resonant kicker as the vector magnet. Starting from the requirements for beam transmission, we derive first the magnet main characteristics (strength, aperture, size and mass) and report the detailed magnetic field calculations in support of the design.
- 21 March 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Applied Superconductivity
- Vol. 34 (5) , 1-5
Open AccessMagnetic Design of a Compact GaToroid for Very High Energy Electron and Pre-Clinical Hadron Beams
GaToroid is a novel configuration of a beam delivery system for charged particles therapy based on a steady-state, axis-symmetric field configuration. The basic idea is to use fixed toroidal magnets, producing an axis-symmetric (or periodical axis-symmetric) field configuration that can bend beams from several directions onto the patient location. In principle, neither magnets nor patient need to be moved. In addition, the field of the magnets of this toroidal gantry is static. Such system is perfectly adapted to FLASH therapy, a novel method of beam dose delivery that has shown benefits for electrons and potential for hadrons. In this paper we describe the magnetic design of a “compact GaToroid”, which could be built with iron-dominated magnets, suitable for 200 MeV electron beams, as well as protons at 70 MeV. The gantry profits from the use of toroidal quadrupoles, which greatly simplify the beam transmission. An additional novelty is the use of a resonant kicker as the vector magnet. Starting from the requirements for beam transmission, we derive first the magnet main characteristics (strength, aperture, size and mass) and report the detailed magnetic field calculations in support of the design.
- Open Access
Proton PBS Planning Techniques, Robustness Evaluation, and OAR Sparing for the Whole-Brain Part of Craniospinal Axis Irradiation
Proton therapy is a promising modality for craniospinal irradiation (CSI), offering dosimetric advantages over conventional treatments. While significant attention has been paid to spine fields, for the brain fields, only dose reduction to the lens of the eye has been reported. Hence, the objective of this study is to assess the potential gains and feasibility of adopting different treatment planning techniques for the entire brain within the CSI target. To this end, eight previously treated CSI patients underwent retrospective replanning using various techniques: (1) intensity modulated proton therapy (IMPT) optimization, (2) the modification/addition of field directions, and (3) the pre-optimization removal of superficially placed spots. The target coverage robustness was evaluated and dose comparisons for lenses, cochleae, and scalp were conducted, considering potential biological dose increases. The target coverage robustness was maintained across all plans, with minor reductions when superficial spot removal was utilized. Single- and multifield optimization showed comparable target coverage robustness and organ-at-risk sparing. A significant scalp sparing was achieved in adults but only limited in pediatric cases. Superficial spot removal contributed to scalp V30 Gy reduction at the expense of lower coverage robustness in specific cases. Lens sparing benefits from multiple field directions, while cochlear sparing remains impractical. Based on the results, all investigated plan types are deemed clinically adoptable.
Open AccessProton PBS Planning Techniques, Robustness Evaluation, and OAR Sparing for the Whole-Brain Part of Craniospinal Axis Irradiation
Proton therapy is a promising modality for craniospinal irradiation (CSI), offering dosimetric advantages over conventional treatments. While significant attention has been paid to spine fields, for the brain fields, only dose reduction to the lens of the eye has been reported. Hence, the objective of this study is to assess the potential gains and feasibility of adopting different treatment planning techniques for the entire brain within the CSI target. To this end, eight previously treated CSI patients underwent retrospective replanning using various techniques: (1) intensity modulated proton therapy (IMPT) optimization, (2) the modification/addition of field directions, and (3) the pre-optimization removal of superficially placed spots. The target coverage robustness was evaluated and dose comparisons for lenses, cochleae, and scalp were conducted, considering potential biological dose increases. The target coverage robustness was maintained across all plans, with minor reductions when superficial spot removal was utilized. Single- and multifield optimization showed comparable target coverage robustness and organ-at-risk sparing. A significant scalp sparing was achieved in adults but only limited in pediatric cases. Superficial spot removal contributed to scalp V30 Gy reduction at the expense of lower coverage robustness in specific cases. Lens sparing benefits from multiple field directions, while cochlear sparing remains impractical. Based on the results, all investigated plan types are deemed clinically adoptable.